As the majority of chordomas show a deletion of the tumour suppressor gene CDKN2A (encoding for the protein p16)17, 18, we provided evidence that the CDK4/6 inhibitor palbociclib may be a promising therapeutic option for chordoma treatment19. This evidence concerns the gene CDKN2A and chordoma.